
PharmNXT Biotech and VERDOT Forge Strategic Partnership to Advance Bioprocessing Technologies in India, Singapore, South Korea and Thailand
Riom, Thane, January 21, 2025 – PharmNXT Biotech, an Indian bioprocessing company, and the French downstream bioprocessing solutions company VERDOT signed a strategic partnership agreement that marks a significant step forward in the field of biopharmaceutical manufacturing.
The collaboration will see PharmNXT Biotech become the major distributor for VERDOT innovative chromatography columns and single-use systems in India, Singapore, South Korea, and Thailand. This partnership brings together PharmNXT Biotech’s extensive offering of bioprocessing solutions, and VERDOT’s cutting-edge chromatography technologies, including their distinctive expertise in large-scale columns.
Charles Ruban, the President and CEO of VERDOT, stated, “PharmNXT Biotech has quickly become a dominant player within the Indian life science industry with a strong reputation for excellence. PharmNXT Biotech’s commitment to customer satisfaction and their established market presence make them the perfect partner for our innovative bioprocessing technologies. Through our combined partnership, we aim to provide biopharmaceutical and biotechnology companies with novel solutions for large-scale and commercial production.”
Nandkumar Thakare, Technical Director of PharmNXT Biotech, remarked, “By integrating VERDOT’s chromatography columns and single-use systems into our product portfolio, we aim to enhance the efficiency and performance of bioprocessing workflows. VERDOT is known for designing and manufacturing high-quality products that drive process efficiency and assist with the development of new biotherapeutic approaches that will result in increasing the accessibility of biopharmaceuticals. We hope that this collaboration can promote industry progress and expand market awareness.”
PharmNXT Biotech and VERDOT will leverage their respective strengths, to facilitate the global exchange of cutting-edge technologies, increase market penetration, promote high-quality products, and heighten awareness and customer adoption. The collaboration is expected to enhance the bioprocessing industry with the addition of high-quality products and technologies. This will enable our clients to reduce the production costs of biotherapeutic products, and extend biopharmaceutical advancements to a broader population, increasing the quality of life for more people.
About VERDOT
VERDOT, established in 1950 and headquartered in Riom, France, stands at the forefront of downstream bioprocessing technology. VERDOT focuses on innovative purification solutions for the biopharmaceutical industry, including chromatography columns, and custom and standardized chromatography and tangential flow filtration (TFF) systems. VERDOT systems and columns are employed in the purification, separation and concentration of biomolecules such as monoclonal antibodies, vaccines, viral vectors (e.g., AAV and lentivirus), and mRNA-based therapeutics.
VERDOT partners with industry leaders in biopharma, research and development, early-stage biotech, and contract development and manufacturing organizations (CDMOs), offering unparalleled expertise across the entire drug development workflow. From initial exploration to the manufacturing of market-ready biologics, VERDOT offers tailored, high-quality purification technologies that enable clients to accelerate time-to-market of groundbreaking therapies.
For more information about VERDOT, visit www.verdot-biotechnologies.com
Media contact
Brian Gerwe, Senior Director, Marketing and Product Management
brian.gerwe@verdot-biotechnologies.com
About PharmNXT Biotech
PharmNXT Biotech is one of the fastest-growing multinational companies in the bioprocessing industry, headquartered in Mumbai, India. Established in 2017, the company is committed to delivering innovative, end-to-end bioprocess solutions and niche technologies to reduce the manufacturing costs of critical lifesaving drugs. In 2022 PharmNXT set up a state-of-the-art manufacturing facility – PharmNXT Ekuse, in Pune.
PharmNXT has expanded its global footprint, supplying products to 12 countries and establishing branches in Singapore and South Korea to support its international operations. With its in-house manufacturing capabilities and a team of experts, PharmNXT provides innovative and scalable bioprocess solutions that adhere to global quality standards. As a trusted partner in bioprocessing, PharmNXT is transforming the industry by making lifesaving drugs more accessible worldwide.
How can our engineering expertise accelerate your innovation?
Reach out to learn more about how we can help you with your downstream processing needs.
